Peter Corr

Peter Bartley Corr is the founder of Auven Therapeutics Management LLLP, serving as Managing General Partner since 2010.
Dr. Corr is also the founder of Imvax, Inc. Current jobs include Non-Executive Director at Analytica Ltd. since 2017, Director at iNOV8 LLC, Director at ADC Therapeutics (UK) Ltd., Member of Alpha Omega Alpha Honor Medical Society, and Member of IOM's Forum.
Former jobs include Executive Chairman & Chief Executive Officer at Lakewood-Amedex, Inc. from 2023 to 2025, Chairman of International Partnership for Microbicides, Chairman of Hever Group, Chairman of Critical Path Institute, Chairman of PhRMA Foundation, Chairman of ADC Therapeutics SA from 2011 to 2020, Independent Director at Furiex Pharmaceuticals, Inc. from 2010 to 2014, Independent Non-Executive Director at CBio Ltd. in 2011, Director at Cibus US LLC, Director at GlobalEdit LLC, Director at Africa Leadership Congress, Senior Vice President-Science & Technology at Pfizer Inc. from 2000 to 2006, Professor-Medicine at Washington University in St. Louis, President-Pharmaceutical Research & Development at Parke Davis Pty Ltd., President-Pharmaceutical Research & Development at Warner Lambert (UK) Ltd., Member-Regents Board at Georgetown University, Senior Vice President-Discovery Research at Monsanto Australia Pty Ltd., Governor at New York Academy of Sciences, and Senior Vice President-Discovery Research at RPG Life Sciences Ltd. Education includes an undergraduate degree from Albany College of Pharmacy & Health Sciences and a doctorate from Georgetown University School of Medicine.